C4 Therapeutics, Inc.

CCCC · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
107
SEC Filings

Business Summary

PART I . Overview We are a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation, or TPD, science to create a new generation of small-molecule medicines that transform patients lives. Leveraging our proprietary TORPEDO platform, we efficiently design and optimize small molecule protein degraders that are highly active against their desired targets by harnessing the bodys natural process for destroying unwanted proteins. Our strategy is to...

Next Earnings

Q2 FY2026 — expected 2026-09-18

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionCCCCdiscussed_in_filing Cybersecurity
topic_mentionCCCCdiscussed_in_filing Trusted Computing
topic_mentionCCCCdiscussed_in_filing Blockchain & Crypto
topic_mentionCCCCdiscussed_in_filing Capital Expenditure
topic_mentionCCCCdiscussed_in_filing Regulation
topic_mentionCCCCdiscussed_in_filing Healthcare & Bio
topic_mentionCCCCdiscussed_in_filing Platform & Ecosystem
topic_mentionCCCCdiscussed_in_filing Sovereign & Government
topic_mentionCCCCdiscussed_in_filing Cybersecurity
topic_mentionCCCCdiscussed_in_filing Trusted Computing
topic_mentionCCCCdiscussed_in_filing Blockchain & Crypto
topic_mentionCCCCdiscussed_in_filing Capital Expenditure
topic_mentionCCCCdiscussed_in_filing Regulation
topic_mentionCCCCdiscussed_in_filing Healthcare & Bio
topic_mentionCCCCdiscussed_in_filing Platform & Ecosystem
topic_mentionCCCCdiscussed_in_filing Sovereign & Government
topic_mentionCCCCdiscussed_in_filing Cybersecurity
topic_mentionCCCCdiscussed_in_filing Trusted Computing
topic_mentionCCCCdiscussed_in_filing Blockchain & Crypto
topic_mentionCCCCdiscussed_in_filing Capital Expenditure

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001628280-26-012000EDGAR94K words
2025-02-272024-12-310001628280-25-008433EDGAR
2024-02-222023-12-310001628280-24-006144EDGAR
2023-02-232022-12-310001628280-23-004711EDGAR
2022-02-242021-12-310001564590-22-006499EDGAR
2021-03-112020-12-310001564590-21-012531EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001628280-25-049854EDGAR61K words
2025-08-072025-06-300001628280-25-038587EDGAR
2025-05-072025-03-310001628280-25-022866EDGAR
2024-10-312024-09-300001628280-24-044411EDGAR
2024-08-012024-06-300001628280-24-033882EDGAR
2024-05-082024-03-310001628280-24-021368EDGAR
2023-11-012023-09-300001628280-23-035793EDGAR
2023-08-082023-06-300001628280-23-027941EDGAR
2023-05-042023-03-310001628280-23-015459EDGAR
2022-11-032022-09-300001628280-22-027985EDGAR
2022-08-042022-06-300001628280-22-020886EDGAR
2022-05-052022-03-310001564590-22-018046EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-260001628280-26-011971EDGAR2K words
2026-01-140001628280-26-002010EDGAR
2025-11-060001628280-25-049850EDGAR
2025-10-160001193125-25-241591EDGAR
2025-10-160001628280-25-045157EDGAR
2025-10-010001628280-25-043290EDGAR
2025-09-220001628280-25-042245EDGAR
2025-08-070001628280-25-038576EDGAR
2025-06-180001628280-25-032155EDGAR
2025-05-070001628280-25-022864EDGAR

107 total filings indexed. 79 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001662579
TickerCCCC
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: f0d353fc2cbbec250af83eb03221ed6e1ad2d25ae33eed650165c05797bc2ae0
parent: 4cda6a8cd2f51e5021412c4a0742f7c5a7e982565f2120bdc6b952989a909185
content hash: 9a90defeff16436157adcde21bcc0d9c2d08553c992b4ffc3db585fb7959ae52
signed: 2026-04-13T04:44:13.874Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf